Damora Therapeutics, Inc. (DMRA) — Total Liabilities
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $20.15M | +1448.6% |
| 2024 | $1.30M | -77.9% |
| 2023 | $5.90M | -48.4% |
| 2022 | $11.44M | +129.1% |
| 2021 | $4.99M | -18.3% |
| 2020 | $6.11M | -25.0% |
| 2019 | $8.14M | — |
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $20.15M | +1448.6% |
| 2024 | $1.30M | -77.9% |
| 2023 | $5.90M | -48.4% |
| 2022 | $11.44M | +129.1% |
| 2021 | $4.99M | -18.3% |
| 2020 | $6.11M | -25.0% |
| 2019 | $8.14M | — |